These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36924644)

  • 21. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.
    Liu DM; Leung TW; Chow PK; Ng DC; Lee RC; Kim YH; Mao Y; Cheng YF; Teng GJ; Lau WY
    Int J Surg; 2022 Jun; 102():106094. PubMed ID: 35662438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
    Hong K; Georgiades CS; Geschwind JF
    Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventional treatment for unresectable hepatocellular carcinoma.
    Murata S; Mine T; Sugihara F; Yasui D; Yamaguchi H; Ueda T; Onozawa S; Kumita S
    World J Gastroenterol; 2014 Oct; 20(37):13453-65. PubMed ID: 25309076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage locoregional therapies for recurrent hepatocellular carcinoma.
    Criss CR; Makary MS
    World J Gastroenterol; 2023 Jan; 29(3):413-424. PubMed ID: 36688022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transarterial ablative therapy of hepatocellular carcinoma].
    Mahnken AH
    Radiologe; 2014 Jul; 54(7):685-93. PubMed ID: 25047524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curative-Intent Therapies in Localized Hepatocellular Carcinoma.
    O'Leary C; Mahler M; Soulen MC
    Curr Treat Options Oncol; 2020 Mar; 21(4):31. PubMed ID: 32193784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey.
    Akarca US; Akhan O; Bilgiç S; Bozkurt MF; Cantaşdemir M; Çermik TF; Çakaloğlu Y; Er Ö; Ilgıt E; Çapa Kaya G; Küçük NÖ; Numan F; Parıldar M; Türkmen C
    Diagn Interv Radiol; 2021 Nov; 27(6):732-739. PubMed ID: 34792027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions.
    Inchingolo R; Posa A; Mariappan M; Spiliopoulos S
    World J Gastroenterol; 2019 Aug; 25(32):4614-4628. PubMed ID: 31528090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma: locoregional and targeted therapies.
    Wong R; Frenette C; Gish R
    Gastroenterol Clin North Am; 2011 Sep; 40(3):599-610. PubMed ID: 21893276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.
    Sherman M; Burak K; Maroun J; Metrakos P; Knox JJ; Myers RP; Guindi M; Porter G; Kachura JR; Rasuli P; Gill S; Ghali P; Chaudhury P; Siddiqui J; Valenti D; Weiss A; Wong R
    Curr Oncol; 2011 Oct; 18(5):228-40. PubMed ID: 21980250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options for intermediate-advanced hepatocellular carcinoma.
    Zhang ZM; Guo JX; Zhang ZC; Jiang N; Zhang ZY; Pan LJ
    World J Gastroenterol; 2011 Apr; 17(13):1685-9. PubMed ID: 21483627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-directed therapy for hepatocellular carcinoma.
    Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC
    Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
    ; ; ; ; ; ; ; ; ;
    J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on transarterial approaches to locoregional treatment in hepatocellular carcinoma.
    Delhaye C; Hendlisz A; Vouche M
    Curr Opin Oncol; 2019 Jul; 31(4):339-345. PubMed ID: 30896451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.